Results 161 to 170 of about 35,220 (306)

Early versus late initiation of long‐acting insulin in paediatric and adult diabetic ketoacidosis: A systematic review and meta‐analysis of randomised control trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic ketoacidosis (DKA) is a serious complication of diabetes, requiring intravenous (IV) insulin until resolution and subsequent transition to subcutaneous insulin. Currently, clinical guidelines vary regarding the timing of long‐acting subcutaneous insulin initiation, with some advocating early administration during IV insulin ...
Bachviet Nguyen   +4 more
wiley   +1 more source

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion. [PDF]

open access: yesDiabetes Technol Ther, 2021
Ziegler R   +5 more
europepmc   +1 more source

A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims A retrospective observational cohort study evaluating real‐world outcomes in adults with type 1 diabetes and gastroparesis using automated hybrid closed loop insulin delivery systems (HCL). Materials and Methods All adults with type 1 diabetes and gastroparesis attending King's College Hospital diabetes service and using continuous ...
Rachael J. L. Tan   +11 more
wiley   +1 more source

Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the efficacy and safety of an automated insulin‐glucagon delivery system (AIGD) compared with an automated insulin delivery system (AID). Materials and methods In a 33‐h, randomised, crossover, inpatient study, 13 participants with type 1 diabetes used the DiaCon system in AIGD and AID modes.
Ajenthen G. Ranjan PhD   +7 more
wiley   +1 more source

Characterisation of steady‐state pharmacokinetics and glucodynamics of once‐weekly insulin efsitora alfa in individuals with type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the steady‐state pharmacokinetics (PK) and glucodynamic effects of insulin efsitora alfa (efsitora) over a weekly interval in adults with type 2 diabetes (T2D). Materials and Methods This open‐label, multiple dose, euglycaemic clamp study was conducted in 56 insulin naïve adults with T2D (mean [±SD] age, 61.9 ± 5.98 years ...
Jennifer Leohr   +11 more
wiley   +1 more source

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes

open access: yesHealth Technology Assessment, 2004
J Colquitt   +4 more
doaj   +1 more source

Economic burden of type 2 diabetes management in France according to clinical characteristics

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim We sought to investigate the treatment, medication patterns, and economic burden of type 2 diabetes (T2D) in France. Materials and Methods This was a descriptive retrospective cross‐sectional study of a representative sample of adults in the national healthcare system claims database in 2022.
Bruno Guerci   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy